title: Hypertension:  an immunologic disease?
authors.forename: Tao
authors.initials: T
authors.lastname: Xing
authors.forename: Feng
authors.initials: F
authors.lastname: Wang
authors.forename: Junhui
authors.initials: J
authors.lastname: Li
authors.forename: Niansong
authors.initials: N
authors.lastname: Wang
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology*; D000075222:Essential Hypertension; D000068800:Etanercept; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007074:Immunoglobulin G / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology
chemical_list: D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept